Brain reserve contributes to distinguishing preclinical Alzheimer’s stages 1 and 2

Yildirim, Z., Delen, F., Berron, D. et al. (42 more authors) (2023) Brain reserve contributes to distinguishing preclinical Alzheimer’s stages 1 and 2. Alzheimer's Research & Therapy, 15. 43. ISSN 1758-9193

Abstract

Metadata

Authors/Creators:
  • Yildirim, Z.
  • Delen, F.
  • Berron, D.
  • Baumeister, H.
  • Ziegler, G.
  • Schütze, H.
  • Glanz, W.
  • Dobisch, L.
  • Peters, O.
  • Freiesleben, S.D.
  • Schneider, L.-S.
  • Priller, J.
  • Spruth, E.J.
  • Schneider, A.
  • Fliessbach, K.
  • Wiltfang, J.
  • Schott, B.-H.
  • Meiberth, D.
  • Buerger, K.
  • Janowitz, D.
  • Perneczky, R.
  • Rauchmann, B.-S.
  • Teipel, S.
  • Kilimann, I.
  • Laske, C.
  • Munk, M.H.
  • Spottke, A.
  • Roy, N.
  • Heneka, M.
  • Brosseron, F.
  • Wagner, M.
  • Roeske, S.
  • Ramirez, A.
  • Ewers, M.
  • Dechent, P.
  • Hetzer, S.
  • Scheffler, K.
  • Kleineidam, L.
  • Wolfsgruber, S.
  • Yakupov, R.
  • Schmid, M.
  • Berger, M.
  • Gurvit, H.
  • Jessen, F.
  • Duzel, E.
Copyright, Publisher and Additional Information: © The Author(s) 2023. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Keywords: Alzheimer’s disease (AD); Brain reserve; Subjective cognitive decline (SCD); Cerebrospinal fluid (CSF); Amyloid pathologic change; Aß42/40 Magnetic resonance imaging (MRI); Hippocampus; Medial temporal lobe; Memory
Dates:
  • Accepted: 8 February 2023
  • Published (online): 28 February 2023
  • Published: 28 February 2023
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Neuroscience (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 06 Mar 2023 11:19
Last Modified: 06 Mar 2023 11:19
Published Version: http://dx.doi.org/10.1186/s13195-023-01187-9
Status: Published
Publisher: Springer Science and Business Media LLC
Refereed: Yes
Identification Number: https://doi.org/10.1186/s13195-023-01187-9

Export

Statistics